include
home
Carousel
About Us
Members
News & Events

Statement About CCR5 Gene-edited Babiesby the Enforcement of Scientific Ethics Committee, Academic Divisions of the Chinese Academy of Sciences(CASAD)

  Statement About CCR5 Gene-edited Babiesby the Enforcement of Scientific Ethics Committee, Academic Divisions of the Chinese Academy of Sciences(CASAD)

 

Recently, several Chinese and foreign media have reported the birth of two babies with edited CCR5 genes. The Enforcement of Scientific Ethics Committee of the Academic Divisions of the Chinese Academy of Sciences (CASAD) has paid much attention to this matter. As the special committee on responsible for guiding the development of scientific ethics and academic discipline, we make the following statement:

We pay great attention to this matter. Under current circumstances, gene editing in human embryos still involves various unresolved technical issues, might lead to unforeseen risks, and violates the consensus of the international scientific community. Therefore, we firmly oppose any individual or entity performing gene editing on the human germline for clinical applications. We would like to cooperate in joint investigations with relevant departments and regions to elucidate the relevant facts. We also appeal to the relevant investigative institutions to disclose the results of their investigation to the public in a timely manner.

  

  

  声明(中文)

 

  中国科学院学部科学道德建设委员会关于免疫艾滋病基因编辑婴儿的声明

 

  近日,国内外媒体爆出免疫艾滋病基因编辑婴儿诞生的消息,对此中国科学院学部高度重视。作为负责组织和领导学部科学道德和学风建设工作的专门委员会,中国科学院学部科学道德建设委员会发表如下声明:

  我们高度关注此事,坚决反对任何个人、任何单位在理论不确定、技术不完善、风险不可控、伦理法规明确禁止的情况下开展人类胚胎基因编辑的临床应用。我们愿意积极配合国家及有关部门和地区开展联合调查,核实有关情况,并呼吁相关调查机构及时向社会公布调查进展和结果。

 

中国科学院学部科学道德建设委员会

2018年11月27日